Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional do INPA |
Texto Completo: | https://repositorio.inpa.gov.br/handle/1/15597 |
Resumo: | Candida spp. is associated with almost 80% of all nosocomial fungal infections and is considered a major cause of blood stream infections. In humans, Cryptococcosis is a disease of the lungs caused by the fungi Cryptococcus gattii and Cryptococcus neoformans. It can be potentially fatal, especially in immune-compromised patients. In a search for antifungal drugs, Deguelia duckeana extracts were assayed against these two fungi and also against Candida albicans, which causes candidiasis. Hexane branches and CH2Cl2 root extracts as well as the substances 4-hydroxylonchocarpine, 3,5,4′-trimethoxy-4-prenylstilbene and 3′,4′-methylenedioxy-7-methoxyflavone were assayed to determine the minimal inhibitory concentration. Phytochemical study of CH2Cl2 root and hexane branch extracts from D. duckeana A.M.G. Azevedo, Fabaceae, resulted in the isolation and characterization of nine phenolic compounds: 4-hydroxyderricine, 4-hydroxylonchocarpine, 3′,4′,7-trimethoxy-flavonol, 5,4′-dihydroxy-isolonchocarpine, 4-hydroxyderricidine, derricidine, 3,5,4′-trimethoxy-stilbene, 3′,4′,7-trimethoxyflavone and yangambin. The only active extract was a CH2Cl2 root showing minimal inhibitory concentration 800 μg/ml against C. gattii, and the investigation of compounds obtained from this extract showed that 4-hydroxylonchocarpine was active against all three fungi (C. neoformans, C. gattii and C. albicans). These results suggest that D. duckeana extracts have potential therapeutic value for the treatment of pathogenic fungi. © 2018 Sociedade Brasileira de Farmacognosia |
id |
INPA-2_838aa8bbbca0626308003057afed35ff |
---|---|
oai_identifier_str |
oai:repositorio:1/15597 |
network_acronym_str |
INPA-2 |
network_name_str |
Repositório Institucional do INPA |
repository_id_str |
|
spelling |
Lima, Nerilson M.Cursino-Hron, Lorena M.Lima, Alita MouraSouza, João Vicente Braga deC., de Oliveira, AndréMarinho, Jane Vasconcelos N.Nunez, C. V.2020-05-15T14:34:13Z2020-05-15T14:34:13Z2018https://repositorio.inpa.gov.br/handle/1/1559710.1016/j.bjp.2018.08.004Candida spp. is associated with almost 80% of all nosocomial fungal infections and is considered a major cause of blood stream infections. In humans, Cryptococcosis is a disease of the lungs caused by the fungi Cryptococcus gattii and Cryptococcus neoformans. It can be potentially fatal, especially in immune-compromised patients. In a search for antifungal drugs, Deguelia duckeana extracts were assayed against these two fungi and also against Candida albicans, which causes candidiasis. Hexane branches and CH2Cl2 root extracts as well as the substances 4-hydroxylonchocarpine, 3,5,4′-trimethoxy-4-prenylstilbene and 3′,4′-methylenedioxy-7-methoxyflavone were assayed to determine the minimal inhibitory concentration. Phytochemical study of CH2Cl2 root and hexane branch extracts from D. duckeana A.M.G. Azevedo, Fabaceae, resulted in the isolation and characterization of nine phenolic compounds: 4-hydroxyderricine, 4-hydroxylonchocarpine, 3′,4′,7-trimethoxy-flavonol, 5,4′-dihydroxy-isolonchocarpine, 4-hydroxyderricidine, derricidine, 3,5,4′-trimethoxy-stilbene, 3′,4′,7-trimethoxyflavone and yangambin. The only active extract was a CH2Cl2 root showing minimal inhibitory concentration 800 μg/ml against C. gattii, and the investigation of compounds obtained from this extract showed that 4-hydroxylonchocarpine was active against all three fungi (C. neoformans, C. gattii and C. albicans). These results suggest that D. duckeana extracts have potential therapeutic value for the treatment of pathogenic fungi. © 2018 Sociedade Brasileira de FarmacognosiaVolume 28, Número 6, Pags. 697-702Attribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccess3,4 Methylenedioxy 7 Methoxyflavone3,4,7 Trimethoxy Flavonol3,4,7 Trimethoxyflavone3,5,4 Trimethoxy 4 Prenylstilbene3,5,4 Trimethoxy Stilbene4 Hydroxyderricidine4 Hydroxyderricine4 Hydroxylonchocarpine5,4 Dihydroxy IsolonchocarpineChalcone DerivativeDeguelia Duckeana ExtractDerricidineFlavone DerivativeFlavonoidPlant ExtractPlant Medicinal ProductUnclassified DrugYangambinAnti-fungal ActivityCarbon Nuclear Magnetic ResonanceCryptococcus GattiiCryptococcus NeoformansCytotoxicityDeguelia DuckeanaLiquid Chromatography-mass SpectrometryMinimum Inhibitory ConcentrationNonhumanPhytochemistryProton Nuclear Magnetic ResonanceAntifungal activity of extracts and phenolic compounds from Deguelia duckeanainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleBrazilian Journal of Pharmacognosyengreponame:Repositório Institucional do INPAinstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPAORIGINALartigo-inpa.pdfartigo-inpa.pdfapplication/pdf663297https://repositorio.inpa.gov.br/bitstream/1/15597/1/artigo-inpa.pdf07f76f981cad39966407c53728a4128cMD511/155972020-07-14 11:24:56.154oai:repositorio:1/15597Repositório de PublicaçõesPUBhttps://repositorio.inpa.gov.br/oai/requestopendoar:2020-07-14T15:24:56Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)false |
dc.title.en.fl_str_mv |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana |
title |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana |
spellingShingle |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana Lima, Nerilson M. 3,4 Methylenedioxy 7 Methoxyflavone 3,4,7 Trimethoxy Flavonol 3,4,7 Trimethoxyflavone 3,5,4 Trimethoxy 4 Prenylstilbene 3,5,4 Trimethoxy Stilbene 4 Hydroxyderricidine 4 Hydroxyderricine 4 Hydroxylonchocarpine 5,4 Dihydroxy Isolonchocarpine Chalcone Derivative Deguelia Duckeana Extract Derricidine Flavone Derivative Flavonoid Plant Extract Plant Medicinal Product Unclassified Drug Yangambin Anti-fungal Activity Carbon Nuclear Magnetic Resonance Cryptococcus Gattii Cryptococcus Neoformans Cytotoxicity Deguelia Duckeana Liquid Chromatography-mass Spectrometry Minimum Inhibitory Concentration Nonhuman Phytochemistry Proton Nuclear Magnetic Resonance |
title_short |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana |
title_full |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana |
title_fullStr |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana |
title_full_unstemmed |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana |
title_sort |
Antifungal activity of extracts and phenolic compounds from Deguelia duckeana |
author |
Lima, Nerilson M. |
author_facet |
Lima, Nerilson M. Cursino-Hron, Lorena M. Lima, Alita Moura Souza, João Vicente Braga de C., de Oliveira, André Marinho, Jane Vasconcelos N. Nunez, C. V. |
author_role |
author |
author2 |
Cursino-Hron, Lorena M. Lima, Alita Moura Souza, João Vicente Braga de C., de Oliveira, André Marinho, Jane Vasconcelos N. Nunez, C. V. |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Lima, Nerilson M. Cursino-Hron, Lorena M. Lima, Alita Moura Souza, João Vicente Braga de C., de Oliveira, André Marinho, Jane Vasconcelos N. Nunez, C. V. |
dc.subject.eng.fl_str_mv |
3,4 Methylenedioxy 7 Methoxyflavone 3,4,7 Trimethoxy Flavonol 3,4,7 Trimethoxyflavone 3,5,4 Trimethoxy 4 Prenylstilbene 3,5,4 Trimethoxy Stilbene 4 Hydroxyderricidine 4 Hydroxyderricine 4 Hydroxylonchocarpine 5,4 Dihydroxy Isolonchocarpine Chalcone Derivative Deguelia Duckeana Extract Derricidine Flavone Derivative Flavonoid Plant Extract Plant Medicinal Product Unclassified Drug Yangambin Anti-fungal Activity Carbon Nuclear Magnetic Resonance Cryptococcus Gattii Cryptococcus Neoformans Cytotoxicity Deguelia Duckeana Liquid Chromatography-mass Spectrometry Minimum Inhibitory Concentration Nonhuman Phytochemistry Proton Nuclear Magnetic Resonance |
topic |
3,4 Methylenedioxy 7 Methoxyflavone 3,4,7 Trimethoxy Flavonol 3,4,7 Trimethoxyflavone 3,5,4 Trimethoxy 4 Prenylstilbene 3,5,4 Trimethoxy Stilbene 4 Hydroxyderricidine 4 Hydroxyderricine 4 Hydroxylonchocarpine 5,4 Dihydroxy Isolonchocarpine Chalcone Derivative Deguelia Duckeana Extract Derricidine Flavone Derivative Flavonoid Plant Extract Plant Medicinal Product Unclassified Drug Yangambin Anti-fungal Activity Carbon Nuclear Magnetic Resonance Cryptococcus Gattii Cryptococcus Neoformans Cytotoxicity Deguelia Duckeana Liquid Chromatography-mass Spectrometry Minimum Inhibitory Concentration Nonhuman Phytochemistry Proton Nuclear Magnetic Resonance |
description |
Candida spp. is associated with almost 80% of all nosocomial fungal infections and is considered a major cause of blood stream infections. In humans, Cryptococcosis is a disease of the lungs caused by the fungi Cryptococcus gattii and Cryptococcus neoformans. It can be potentially fatal, especially in immune-compromised patients. In a search for antifungal drugs, Deguelia duckeana extracts were assayed against these two fungi and also against Candida albicans, which causes candidiasis. Hexane branches and CH2Cl2 root extracts as well as the substances 4-hydroxylonchocarpine, 3,5,4′-trimethoxy-4-prenylstilbene and 3′,4′-methylenedioxy-7-methoxyflavone were assayed to determine the minimal inhibitory concentration. Phytochemical study of CH2Cl2 root and hexane branch extracts from D. duckeana A.M.G. Azevedo, Fabaceae, resulted in the isolation and characterization of nine phenolic compounds: 4-hydroxyderricine, 4-hydroxylonchocarpine, 3′,4′,7-trimethoxy-flavonol, 5,4′-dihydroxy-isolonchocarpine, 4-hydroxyderricidine, derricidine, 3,5,4′-trimethoxy-stilbene, 3′,4′,7-trimethoxyflavone and yangambin. The only active extract was a CH2Cl2 root showing minimal inhibitory concentration 800 μg/ml against C. gattii, and the investigation of compounds obtained from this extract showed that 4-hydroxylonchocarpine was active against all three fungi (C. neoformans, C. gattii and C. albicans). These results suggest that D. duckeana extracts have potential therapeutic value for the treatment of pathogenic fungi. © 2018 Sociedade Brasileira de Farmacognosia |
publishDate |
2018 |
dc.date.issued.fl_str_mv |
2018 |
dc.date.accessioned.fl_str_mv |
2020-05-15T14:34:13Z |
dc.date.available.fl_str_mv |
2020-05-15T14:34:13Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://repositorio.inpa.gov.br/handle/1/15597 |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.bjp.2018.08.004 |
url |
https://repositorio.inpa.gov.br/handle/1/15597 |
identifier_str_mv |
10.1016/j.bjp.2018.08.004 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Volume 28, Número 6, Pags. 697-702 |
dc.rights.driver.fl_str_mv |
Attribution-NonCommercial-NoDerivs 3.0 Brazil http://creativecommons.org/licenses/by-nc-nd/3.0/br/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivs 3.0 Brazil http://creativecommons.org/licenses/by-nc-nd/3.0/br/ |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Brazilian Journal of Pharmacognosy |
publisher.none.fl_str_mv |
Brazilian Journal of Pharmacognosy |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional do INPA instname:Instituto Nacional de Pesquisas da Amazônia (INPA) instacron:INPA |
instname_str |
Instituto Nacional de Pesquisas da Amazônia (INPA) |
instacron_str |
INPA |
institution |
INPA |
reponame_str |
Repositório Institucional do INPA |
collection |
Repositório Institucional do INPA |
bitstream.url.fl_str_mv |
https://repositorio.inpa.gov.br/bitstream/1/15597/1/artigo-inpa.pdf |
bitstream.checksum.fl_str_mv |
07f76f981cad39966407c53728a4128c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
repository.name.fl_str_mv |
Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA) |
repository.mail.fl_str_mv |
|
_version_ |
1809928877071400960 |